Immunogenicity of Lactobacillus-expressing VP2 and VP3 of the infectious pancreatic necrosis virus (IPNV) in rainbow trout

Fish and Shellfish Immunology

Volumn 32, Issue 1, 2012, Pages 196-203

  Min, Liu ^a   Li Li, Zhao ^a   Jun Wei, Ge ^a   Xin Yuan, Qiao ^a   Yi Jing, Li ^a   Di Qiu, Liu ^b  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^b KUNMING INSTITUTE OF ZOOLOGY   (China)

Author keywords

Infectious pancreatic necrosis virus (IPNV); Lactobacillus; Oral vaccine; Rainbow trout; VP2 and VP3

Indexed keywords

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; INFECTIOUS PANCREATIC NECROSIS VIRUS; LACTOBACILLUS; LACTOBACILLUS CASEI; MIRIDAE; ONCORHYNCHUS MYKISS; SALMONIDAE;

VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIRNAVIRUS INFECTION; BLOOD; FISH DISEASE; GENETICS; IMMUNOLOGY; INFECTIOUS PANCREATIC NECROSIS VIRUS; LACTOBACILLUS; RAINBOW TROUT; VIROLOGY; VIRUS LOAD;

ANIMALS; ANTIBODIES, VIRAL; BIRNAVIRIDAE INFECTIONS; FISH DISEASES; INFECTIOUS PANCREATIC NECROSIS VIRUS; LACTOBACILLUS; ONCORHYNCHUS MYKISS; VIRAL LOAD; VIRAL VACCINES;

EID: 84859236399     PISSN: 10504648     EISSN: 10959947     Source Type: Journal    
DOI: 10.1016/j.fsi.2011.11.015     Document Type: Article

References (47)

1. Wolf K., Snieszko S.F., Dunbar C.E., Pyle E. Virus nature of infectious pancreatic necrosis in trout. Proc Soc Exp Biol Med 1960, 104:105-108.
2. Roberts R.J., Pearson M.D. Infectious pancreatic necrosis in Atlantic salmon, Salmo salar L. J Fish Dis 2005, 28:383-390.
3. Cutrin J., Lopez-Vazquez C., Olveira J., Castro S., Dopazo C., Bandin I. Isolation in cell culture and detection by PCR-based technology of IPNV-like virus from leucocytes of carrier turbot, Scophthalmus maximus (L.). J Fish Dis 2005, 28:713-722.
4. Rodriguez S., Alonso M., Perez-Prieto S. Detection of infectious pancreatic necrosis virus (IPNV) from leukocytes of carrier rainbow trout Oncorhynchus mykiss. Fish Pathol 2001, 36:139-146.
5. Garcia J., Urquhart K., Ellis A. Infectious pancreatic necrosis virus establishes an asymptomatic carrier state in kidney leucocytes of juvenile Atlantic cod, Gadus morhua L. J Fish Dis 2006, 29:409-413.
6. Coulibaly F., Chevalier C., Gutsche I., Pous J., Navaza J., Bressanelli S., et al. The birnavirus crystal structure reveals structural relationships among icosahedral viruses. Cell 2005, 120:761-772.
7. Duncan R., Mason C.L., Nagy E., Leong J.A., Dobos P. Sequence analysis of infectious pancreatic necrosis virus genome segment B and its encoded VP1 protein: a putative RNA-dependent RNA polymerase lacking the Gly-Asp-Asp motif. Virology 1991, 181:541-552.
8. Gorbalenya A.E., Pringle F.M., Zeddam J.L., Luke B.T., Cameron C.E., Kalmakoff J., et al. The palm subdomain-based active site is internally permuted in viral RNA-dependent RNA polymerases of an ancient lineage. J Mol Biol 2002, 324:47-62.
9. Galloux M., Chevalier C., Henry C., Huet J.C., Costa B.D., Delmas B. Peptides resulting from the pVP2 C-terminal processing are present in infectious pancreatic necrosis virus particles. J Gen Virol 2004, 85:2231.
10. Fridholm H., Eliasson L., Everitt E. Immunogenicity properties of authentic and heterologously synthesized structural protein VP2 of infectious pancreatic necrosis virus. Viral Immunol 2007, 20:635-648.
11. Frost P., Börsheim K., Endresen C. Analysis of the antibody response in Atlantic salmon against recombinant VP2 of infectious pancreatic necrosis virus (IPNV). Fish Shellfish Immunol 1998, 8:447-456.
12. Tarrab E., Berthiaume L., Grothe S., O'Connor-McCourt M., Heppell J., Lecomte J. Evidence of a major neutralizable conformational epitope region on VP2 of infectious pancreatic necrosis virus. J Gen Virol 1995, 76:551.
13. Hsu Y.L., Chen C.C., Wu J.L. Molecular relationships in infectious pancreatic necrosis virus. Virus Res 1995, 37:239-252.
14. Villena J., Salva S., Aguero G., Alvarez S. Immunomodulatory and protective effect of probiotic Lactobacillus casei against Candida albicans infection in malnourished mice. Microbiol Immunol 2011, 55:434-445.
15. Liu D., Wang X., Ge J., Liu S., Li Y. Comparison of the immune responses induced by oral immunization of mice with Lactobacillus casei-expressing porcine parvovirus VP2 and VP2 fused to Escherichia coli heat-labile enterotoxin B subunit protein. Comp Immunol Microbiol Infect Dis 2011, 34:73-81.
16. Wei C.H., Liu J.K., Hou X.L., Yu L.Y., Lee J.S., Kim C.J. Immunogenicity and protective efficacy of orally or intranasally administered recombinant Lactobacillus casei expressing ETEC K99. Vaccine 2010, 28:4113-4118.
17. Hou X.L., Yu L.Y., Liu J., Wang G.H. Surface-displayed porcine epidemic diarrhea viral (PEDV) antigens on lactic acid bacteria. Vaccine 2007, 26:24-31.
18. Pouwels P.H., Leer R.J., Boersma W.J.A. The potential of Lactobacillus as a carrier for oral immunization: development and preliminary characterization of vector systems for targeted delivery of antigens. J Biotechnol 1996, 44:183-192.
19. Claassen E., Van Winsen R., Posno M., Boersma W. New and safe " oral" live vaccines based on Lactobacillus. Adv Exp Med Biol 1995, 371:1553.
20. Galdeano C.M., Perdigon G. The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin Vaccine Immunol 2006, 13:219.
21. Ogawa T., Asai Y., Sakamoto H., Yasuda K. Oral immunoadjuvant activity of Lactobacillus casei subsp. casei in dextran-fed layer chickens. Br J Nutr 2006, 95:430-434.
22. Allnutt F.C., Bowers R.M., Rowe C.G., Vakharia V.N., LaPatra S.E., Dhar A.K. Antigenicity of infectious pancreatic necrosis virus VP2 subviral particles expressed in yeast. Vaccine 2007, 25:4880-4888.
23. Dhar A.K., Bowers R.M., Rowe C.G., Allnutt F.C. Expression of a foreign epitope on infectious pancreatic necrosis virus VP2 capsid protein subviral particle (SVP) and immunogenicity in rainbow trout. Antivir Res 2010, 85:525-531.
24. de las Heras A.I., Rodriguez Saint-Jean S., Perez-Prieto S.I. Immunogenic and protective effects of an oral DNA vaccine against infectious pancreatic necrosis virus in fish. Fish Shellfish Immunol 2010, 28:562-570.
25. de Las Heras A.I., Perez Prieto S.I., Rodriguez Saint-Jean S. In vitro and in vivo immune responses induced by a DNA vaccine encoding the VP2 gene of the infectious pancreatic necrosis virus. Fish Shellfish Immunol 2009, 27:120-129.
26. Perez-Prieto S., Garcia-Rosado E., Rodriguez S., Castro D., Borrego J.J. Antigenic properties and experimental transmission to several fish species of a marine birnavirus isolated from sole (Solea senegalensis). Vet Microbiol 2001, 82:11-25.
27. Hill B., Williams R., Finlay J. Preparation of antisera against fish virus disease agents. Dev Biol Stand 1981, 49:209-218.
28. Ho P.S., Kwang J., Lee Y.K. Intragastric administration of Lactobacillus casei expressing transmissible gastroentritis coronavirus spike glycoprotein induced specific antibody production. Vaccine 2005, 23:1335-1342.
29. Min Liu, Li-li Zhao, Jun-wei Ge, Di Ou, Xiang-qing Wand, Yi Liu, et al. Construction of expression system of infectious pancreas necrosis virus VP3 protein in Lactobacillus casei. Freshwater Fish 2008, 38:30-34. [Chinese].
30. Cortes-Perez N.G., Bermudez-Humaran L.G., Le Loir Y., Rodriguez-Padilla C., Gruss A., Saucedo-Cardenas O., et al. Mice immunization with live lactococci displaying a surface anchored HPV-16 E7 oncoprotein. FEMS Microbiol Lett 2003, 229:37-42.
31. Yigang X.U., Yijing L.I. Construction of recombinant Lactobacillus casei efficiently surface displayed and secreted porcine parvovirus VP2 protein and comparison of the immune responses induced by oral immunization. Immunology 2008, 124:68-75.
32. Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am J Epidemiol 1938, 27:493.
33. Bowers R.M., Lapatra S.E., Dhar A.K. Detection and quantitation of infectious pancreatic necrosis virus by real-time reverse transcriptase-polymerase chain reaction using lethal and non-lethal tissue sampling. J Virol Methods 2008, 147:226-234.
34. Mutwiri G., Watts T., Lew L., Beskorwayne T., Papp Z., Baca-Estrada M.E., et al. Ileal and jejunalPeyer's patches play distinct roles in mucosal immunity of sheep. Immunology 1999, 97:455-461.
35. Zhang Y., Pacheco S., Acuna C.L., Switzer K.C., Wang Y., Gilmore X., et al. Immunoglobulin A-deficient mice exhibit altered T helper 1-type immune responses but retain mucosal immunity to influenza virus. Immunology 2002, 105:286-294.
36. Reveneau N., Geoffroy M.C., Locht C., Chagnaud P., Mercenier A. Comparison of the immune responses induced by local immunizations with recombinant Lactobacillus plantarum producing tetanus toxin fragment C in different cellular locations. Vaccine 2002, 20:1769-1777.
37. Seegers J.F.M.L. Lactobacilli as live vaccine delivery vectors: progress and prospects. Trends Biotechnol 2002, 20:508-515.
38. Mannam P., Jones K.F., Geller B.L. Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes. Infect Immun 2004, 72:3444.
39. Lee J.S., Poo H., Han D.P., Hong S.P., Kim K., Cho M.W., et al. Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice. J Virol 2006, 80:4079-4087.
40. Mercenier A., Muller-Alouf H., Grangette C. Lactic acid bacteria as live vaccines. Curr Issues Mol Biol 2000, 2:17-26.
41. Pouwels P.H., Leer R.J., Shaw M., Heijne den Bak-Glashouwer M.J., Tielen F.D., Smit E., et al. Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes. Int J Food Microbiol 1998, 41:155-167.
42. Temin H.M. Overview of biological effects of addition of DNA molecules to cells. Dev Biol Stand 1998, 93:37-44.
43. Wolff J.A., Ludtke J.J., Acsadi G., Williams P., Jani A. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet 1992, 1:363-369.
44. Cernescu C. Nucleic acid vaccines. Rom J Virol 1995, 46:69-73.
45. Smith H.A. Regulatory considerations for nucleic acid vaccines. Vaccine 1994, 12:1515-1519.
46. Robertson J.S. Safety considerations for nucleic acid vaccines. Vaccine 1994, 12:1526-1528.
47. Moon C.H., Do J.W., Cha S.J., Bang J.D., Park M.A., Yoo D.J., et al. Comparison of the immunogenicity of recombinant VP2 and VP3 of infectious pancreatic necrosis virus and marine birnavirus. Arch Virol 2004, 149:2059-2068.